Back

TransCode Therapeutics secures Australian and Japanese patent milestones for RNA cancer therapies

Verifying
  • TransCode Therapeutics announced Australian and Japanese patent developments for RNA-based cancer therapies.
  • Australia accepted a patent application, while Japan issued a patent to TransCode Therapeutics.
  • The patents cover nanoparticle delivery systems and RNA compositions.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.